Homedrug manufacturer par

drug manufacturer par

Aradigm Corporation Dropped More Than 30% Today, Here’s Why

Aradigm Corporation Dropped More Than 30% Today, Here’s Why

January 9, 2018

Head-to-Head: Impax Laboratories VS. SCYNEXIS

Head-to-Head: Impax Laboratories VS. SCYNEXIS

October 24, 2017

Is Impax Laboratories a Buy At $16?

Health Services

Is Impax Laboratories a Buy At $16?

October 20, 2017

Impax Laboratories Inc: A Technical Snapshot

Impax Laboratories Inc: A Technical Snapshot

October 19, 2017

An Analysis of pSivida Corp.

An Analysis of pSivida Corp.

October 2, 2017

Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

September 26, 2017

Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

September 21, 2017

Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval

Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval

August 25, 2017

Horizon Pharma Increased More Than 13% Today, Here’s Why

Horizon Pharma Increased More Than 13% Today, Here’s Why

August 17, 2017

Shares of Synergy Pharmaceuticals are Falling Today and This is Why

Shares of Synergy Pharmaceuticals are Falling Today and This is Why

August 10, 2017

« 1 2 3 »